In particular, the enzyme undergoes an apparent 'open to closed' transition on ligand binding. This contraction involved not only the activation site but also the C-terminal tRNA recognition motif (Fig. 1b) .
The active-site cavity is mainly formed by motif 2, motif 3 and two loop regions connecting b4-b5 and b5-b6, respectively ( Fig. 1a and Supplementary Fig. 3 ). The active-site cavities of the various enzyme structures were calculated for different states with the program Hollow 19 . The solvent-accessible surface around the active site was computed with a probe radius of 1.4 Å (approximating a water molecule). This shell defined the ligand-binding space formed by the enzyme. From this calculation, the cavity of the apoenzyme is seen clearly as wide open (Fig. 1c) , with a space at the amino-acid-binding site much larger than is required to fit the cognate amino acid (alanine). Binding of AMP-PCP induced a marked contraction of the active centre that shrank the amino-acid-binding site and the adenylate-binding site ( Fig. 1c ). With this contraction, the space available for amino-acid binding became even smaller than that needed to fit alanine. In particular, when bound to AMP-PCP, the space for the amino group of alanine was partly occupied by the indole side chain of Trp 170 ( Fig. 1c ). When alanine was bound to the amino-acid site together with ATP to form the Ala-AMP adenylate, Trp 170 swung back slightly ( Fig. 1c, d) . Thus, the enzyme did not preform a rigid amino-acid-binding pocket, but rather was adjustable to the binding ligands. Replacing Ala-AMP with the Ala-SA analogue resulted in a similar structure (r.m.s.d. 0.15 Å , for residues within 5 Å of the ligands).
Structures with Ser-SA and Gly-SA had similar resolutions (about 1.9 Å ) and the same space group (P4 1 2 1 2) as the complex with Ala-SA. The structures of the three adenylate analogue complexes closely resemble each other (maximum r.m.s.d. 0.18 Å ). The calculated active-site cavities showed no apparent differences between these three structures, and all cavity-forming residues aligned to the same positions ( Fig. 1e ). After superimposition of the three proteins, the adenylate parts of all three ligands-adenosine, ribose and sulphuralso aligned closely. Thus, all three amino acids bound to almost identical positions in the active site (r.m.s.d. 0.14 Å ). Only Cb of serine rotated by 0.53 Å in comparison with Cb of alanine. This rotation allowed the extra hydroxyl group of serine to fit snugly into the lower side of the amino-acid pocket. A small cavity right under the amino-acid site is partly filled by three stably bound water molecules (found in all three complex structures; Fig. 1e ). No apparent change of pocket size occurred on binding of serine (no expansion) or glycine (no shrinkage).
Similarly to alanine, the a-amino group of serine forms a hydrogen bond with the carboxyl group of Asp 235 ( Fig. 2a, b, d ). In addition, the carboxyl group of serine forms a hydrogen bond with the class II invariant Arg 69 on motif 2. The same Arg 69 forms a salt bridge with the a-sulphate of the adenylate analogue, and this interaction is critical for catalysing the activation reaction of class II enzymes 20, 21 .
A conserved residue, Asn 212, is hydrogen-bonded with the bridging nitrogen between the seryl moiety and AMP (replaced by O in the natural adenylate). When an amino acid was absent, the side chain of Asn 212 swung to bind to the a-phosphate of AMP-PCP. These interactions are also observed in the structures of AlaRS 441-LZ with Ala-SA and Gly-SA, with almost all coordinates of the AlaRS 441-LZ residues within the binding pocket being the same, regardless of the bound amino acid ( Fig. 2a , c). This common main-chain conformation may explain why cognate and non-cognate amino acids have similar k cat values and are differentiated mainly by their respective K m values 22 .
In contrast with serine, a-aminobutyrate is not activated by AlaRS, possibly because the larger size of CH 3 (compared with that of OH) blocks the entry of a-aminobutyrate into the active site 13 . However, our structures show that serine forms interactions (with the enzyme) that are not possible with a-aminobutyrate. Two extra hydrogen bonds pin down the hydroxyl group. One is from the G237 backbone NH, whereas the other is from the carboxyl group of Asp 235 ( Fig. 2b ). As mentioned above, the carboxyl group of Asp 235 (conserved in all AlaRSs) also holds the a-NH 3 1 group of serine, alanine and glycine. (This finding, in the present work, sheds light on the lethality of a previously described D235A substitution in E. coli AlaRS, which a kinetic analysis suggested was due in large part to the role of D235 in transferring the aminoacyl group from the adenylate to tRNA 23 , probably by stabilizing the transition state 24 .) The necessity of holding the a-amino group (of the cognate substrate alanine) through an acidic group therefore creates the dilemma of not being able to avoid serendipitous binding to the serine OH. The interactions flowing from Asp 235 are major determinants in the binding of serine to AlaRS (see below).
A close inspection of the structure showed that the serine OH is only 3.3 Å away from the Ca of G237 in motif 3, b7 (Fig. 2b ). Binding of serine does not induce any apparent movement of b7, which is the central b-strand in the class II-defining b-sheet cradle and is therefore the least flexible compared with other parts of the cradle. This lack of flexibility may explain why the K m for serine is 600-fold that for alanine ( Fig. 3a) . Because of the close approach of the serine OH to the Ca of G237, the pocket would probably be shrunk by substituting a slightly bulkier residue for G237. Pursuant to this idea, G237A AlaRS 441 (without a leucine zipper) was made. In the standard amino-acid-dependent ATP-PP i exchange assay (Fig. 3a-c) , which follows the rate of synthesis of the adenylate, G237A AlaRS 441 had a sharply elevated K m for alanine (1,250-fold increase) (Fig. 3a ). This sharp drop in affinity for alanine was expected, because the distance between the Ca of G237 and Cb of alanine is 3.8 Å , and the extra b-CH 3 present in G237A AlaRS 441 would crowd the bound alanine. Next we found that G237A AlaRS 441 showed only a small change in the K m for glycine. This result is consistent with the introduced extra b-CH 3 of G237A AlaRS 441 affecting only the b-position of a bound amino-acid substrate (Fig. 3c) . Although serine is the bulkiest of the three amino acids, G237A AlaRS 441 bound to serine with a similar affinity as that of wild-type AlaRS 441 (Fig. 3b) . Therefore, within limits, the pocket size does not have a key function in serine binding.
To achieve further clarity on the reason for serine being insensitive to the shrinkage of the pocket size, we crystallized G237A AlaRS 441-LZ bound to each of the analogues Ala-SA, Gly-SA and Ser-SA (Fig. 3d-f ). As expected, the G237A mutation introduced bulk into the alanine-binding pocket, with little other change in the pocket or the surrounding atoms. The steric crowding of alanine with the introduced Cb in G237A AlaRS 441-LZ is apparent in the small separation of Cb of alanine from Cb of A237 (3.6 Å ; Fig. 3d ). This crowding easily explains the sharply elevated K m for alanine of G237A AlaRS 441-LZ .
As expected, bound Gly-SA was little affected by the extra bulk from the b-CH 3 introduced at position 237 in G237A AlaRS 441-LZ (Fig. 3f ). For that reason, the K m for glycine was virtually unchanged. However, for serine, crowding by the introduced Cb of G237A AlaRS 441-LZ is clear. And yet, whereas crowding at the Cb positions of A237 and serine occurs (which breaks the hydrogen bond between backbone NH of G237A and the serine OH and extends the separation to 4.0 Å ), the carboxyl of Asp 235 remains hydrogen-bonded to the serine OH and the a-NH 3 1 (Fig. 3e) . Thus, the bifurcated interactions between Asp 235 and serine seem to be a major cause of the inability of the enzyme to evolve to a higher discrimination against serine.
Inspection of the k cat and k cat /K m values for the three amino acids, with native AlaRS 441 and G237A AlaRS 441 , further showed the difficulty of resolving the dilemma posed by the structural design of the enzyme. Because of the extra bulk introduced by the G237A substitution, the carboxyl of serine shifts 0.3 Å towards motif 3 (Fig. 3e ) and this shift may in turn explain why the k cat for serine activation is greatly decreased (Fig. 3b ). However, the desirable outcome of decreasing the kinetic activation of serine comes at a high price. The shrinking of the pocket (in the hope of excluding serine) sharply raised the K m for alanine but at the same time did not greatly perturb the K m for serine, or did not provide a sufficient offsetting decrease in k cat for serine. The problem is further compounded for glycine (as expected, the k cat /K m ratio for glycine was least affected by the mutation), which is more than 150-fold more competitive against alanine with G237A AlaRS 441 than with wildtype AlaRS 441 .
Because D235 is the major reason for the binding of serine in the pocket for alanine, we investigated whether this specificity problem could be solved by changing (D235E) or removing (D235N, D235Q) the acidic group or the side chain (D235A) of D235 ( Fig. 4a , Supplementary Fig. 6 and Supplementary Information). None of these substitutions improved the discrimination between Ala and Ser. For example, the frequency of misincorporating serine, relative to incorporating alanine, was much greater with the D235N and D235A mutants than with the wild-type enzyme ( Supplementary  Figs 6 and 7) . Collectively, these results further highlight the dilemma that creates this 'serine paradox', and how difficult it is to bypass Asp 235.
While they are continuously challenged by canonical and noncanonical amino acids, AARSs control the fidelity of the genetic code on the protein synthesis production line. Only AlaRS and ThrRS are known to misactivate both smaller and larger non-cognate amino acids. However, the problematic larger amino acid (hydroxynorvaline) for ThrRS does not occur naturally 25 . For that reason, ThrRS has no selective pressure for rejecting hydroxynorvaline. In contrast, AlaRSs are challenged by canonical amino acids, both the smaller glycine and the larger serine.
The work described above shows that this serine paradox is rooted in a dilemma that flows out of the ancient design of AlaRSs. For both class I and class II enzymes, the ancient scaffold simultaneously captures the a-amino and a-carboxyl groups of the amino-acid substrate. A natural consequence of this circumstance is the need for an acidic residue to pin down the a-NH 3 1 group. In contrast with previous understanding 26 , the way in which this is done is idiosyncratic to the synthetase, and many synthetases have found alternative residues during evolution ( Fig. 4b and Supplementary Fig. 8 ). Asp 235 is universally conserved in AlaRSs across all three kingdoms of life. This deeply rooted architecture causes the serine-interaction paradox for AlaRSs, and the interaction of Asp 235 with the serine OH is so robust that it was retained even after the creation of a shrunken pocket with the G237A substitution ( Fig. 3 AlaRS, the groups that bind the a-NH 3 1 group in SerRS and ThrRS (glutamate or zinc) are also used to recognize the c-OH group of their cognate substrates 25, 27 (Fig. 4c) .
The structural architecture of class II (and class I) tRNA synthetases goes back to the last universal common ancestor about 3.5 billion years ago. Asp 235 has been in place in AlaRSs for that entire time. Despite billions of years of evolution, an alternative to Asp 235, within the context of the structural scaffold of class II enzymes, has not been found. Apparently unable to find a better architecture for the recognition of alanine, the problem of serine misactivation was solved through the free-standing AlaXps. (Indeed, in a bacterial model, AlaXp rescued a cell from serine toxicity 15 .) These proteins appeared contemporaneously with the early AlaRSs 17 . No doubt this solution removed much of the evolutionary pressure to find a variation of the structural architecture of AlaRS that would solve the serine paradox ( Supplementary Fig. 1 ).
METHODS SUMMARY
To aid crystallization, a 'leucine-zipper' mutation 28 (His104Leu, Gln108Leu, Glu112Leu) was created in an active 441-residue fragment of E. coli AlaRS. Wild-type and mutant E. coli AlaRS 441-LZ proteins were overexpressed from E. coli and purified by fast protein liquid chromatography. The ligand complexes were generated by mixing at 4 uC the protein with Ala-SA, Ser-SA, Gly-SA, AMP-PCP, or alanine and AMP-PCP together, with 10 mM MgCl 2 and 10 mM 2-mercaptoethanol. Crystals were obtained by the micro-sitting-drop vapour diffusion method. All wild-type and mutant AlaRS 441-LZ complex structures were determined by molecular replacement with the apo-AlaRS structure from A. aeolicus (Protein Data Bank accession code 1RIQ) as the initial model. The ATP-pyrophosphate exchange assays were performed at 22 uC in a buffer composed of 100 mM Tris-HCl pH 8.0, 1 mM ATP, 10 mM MgCl 2 , 10 mM KF, 0.1 mg ml 21 BSA, 5 mM 2-mercaptoethanol and 0.5 mM Na-32 PP i . Linear initial rates were determined by measurements of the incorporation of 32 PP i into ATP at four sequential time intervals of 3 min each, and the data were fitted to the Michaelis-Menten equation with KaleidaGraph.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
